WIN 66306, a new neuroknin antagonist produced by an Aspergillus species: Fermentation, isolation and physico-chemical properties.

The Journal of Antibiotics
1994.0

Abstract

WIN 66306 (1a), a cyclic peptide containing a novel amino acid, was isolated as a neurokinin antagonist from an Aspergillus species, labelled SC230. Conditions that maximized the production of 1a were developed, leading also to production of the related compound WIN 68577 (2) and rosellichalasin (3). Both 2 and 3 were more active in the rat NK1 than in the human NK1 receptor binding assay, while 1a was more active at the human receptor with an inhibitor affinity constant of 7 microM.

Knowledge Graph

Similar Paper

WIN 66306, a new neuroknin antagonist produced by an Aspergillus species: Fermentation, isolation and physico-chemical properties.
The Journal of Antibiotics 1994.0
WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. I. Fermentation and isolation.
The Journal of Antibiotics 1994.0
WIN 64821, a new competitive antagonist to substance P, isolated from an Aspergillus species: structure determination and solution conformation
The Journal of Organic Chemistry 1993.0
Structure, determination, pharmacological evaluation, and structure-activity studies of a new cyclic peptide substance P antagonist containing the new amino acid 3-prenyl-.beta.-hydroxytyrosine isolated from Aspergillus flavipes
Journal of Medicinal Chemistry 1994.0
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.
The Journal of Antibiotics 1985.0
Sch 217048:  A Novel Cyclodepsipeptide with Neurokinin Antagonist Activity
The Journal of Organic Chemistry 1998.0
Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties.
The Journal of Antibiotics 1988.0
Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties.
The Journal of Antibiotics 1988.0
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.
The Journal of Antibiotics 1985.0
A Family of Depsi-peptide Fungal Metabolites, as Selective and Competitive Human Tachykinin Receptor (NK2) Antagonists. Fermentation, Isolation, PhysicQ-chemical Properties, and Biological Activity.
The Journal of Antibiotics 2001.0